Comparison of the Reflectance Method (Reflotron® Reflectance Photometer) with the Absorbance Method (Automatic Analysers) for the Determination of Cholesterol by Assmann, G. et al.
Assmann et al.: Cholesterol determination: Reflectance versus absorbance method 961
J. Clin. Chem. Clin. Biochem.
Vol. 27, 1989, pp. 961-966
© 1989 Walter de Gruyter & Co.
Berlin · New York
Comparison of the Reflectance Method
(Reflotron® Reflectance Photometer) with the Absorbance Method
(Automatic Analysers) for the Determination of Cholesterol
By G. Assmann1), H. Brinkers
Institutför Klinische Chemie und Laboratoriumsmedizin, Westfälische Wilhelms-Universität, Münster, FRG
H. Schulte
Institut fär Arterioskleroseforschung an der Westfälischen Wühelms-Universität, Münster, FRG and
C. A. Carstensen
Boehringer Mannheim GmbH, Mannheim, FRG
\ (Received June 12/September 7, 1989)
Summary: The European Atherosclerosis Society (1) and the Expert Panel of the US National Cholesterol
Education Program (2) have issued detailed guide values for recognition and management of hyperlipidaemia
in adults. In these guidelines, the diagnosis of dyslipidaemia based on the measurements of total Cholesterol,
triacylglycerols, HDL and LDL Cholesterol plays an important role.
A prerequisite for the desired success of interventive measures is the reliability of the analytical data. The aim
of this study was to investigate the precision and accuracy of Reflotron® Cholesterol, a method based on the
dry chemistry principle.
Accuracy was assessed by establishing the correlation with the standardized automated methods used in
routine lipid diagnosis. In addition, it was also examined whether the Reflotron® Cholesterol results in plasma
and blood are comparable. The Reflotron® Cholesterol (sample: blood) showed a good correlation with the
CHOD/PAP method on a Hitachi 737 Instrument (sample: plasma). The median value of the differences of
the test results was -^0.4%. Similarly, the method comparison of Reflotron® Cholesterol (sample: blood)
versus CHOD/PAP method on a SMAC Instrument (sample: plasma) showed that Reflotron® produces
slightly (1.8%) higher results. The Refloton® Cholesterol values obtained from blood samples were slightly
lower thän those ffom plasma samples (median value of the differences: —2.2%).
The results $iiggest thät for routine purposes Reflotron® Cholesterol provides results which are in good
agreement with those obtained by standardized wet chemistry methods.
Introduction a report with the title «Current Status of Blood cho.
The Laboratory Standardization Panel of the Na- lesterol Measurement in Clinical Laboratories in the
tional Cholesterol Education has recently published United States" (3). This report shows the considerable
variance of enzymatic Cholesterol determinations on
the usual laboratory Instruments when the same sam-
') On the occ^ion of the 25* ̂ *^·***. °™ ple material is used. A total of 25 Systems were ex-Society for Glmical Chemistry (cf. Editonal, this J. 27, 529 . . - ,**** , v ,
(1989)). ammed. Seven Systems (l 884 samples) showed system-
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atic deviations < -5%, and 7 Systems (425 samples)
showed deviations > +5%, the coefficients of Vari-
ation (CVs) lying in the 2.2% to 8.8% ränge with a
median value of 5.4%, i.e. the CVs of 14 Systems
(56%) were > 5% (3). According to the requirements
of the Laboratory Standardization Panel, the coeffi-
cients of Variation for cholesterol determinations
should be < 5% and the deviations < ±5% of the
"true" values. Coefficients of Variation and deviations
of < 3%, however, are aimed at I.e. (3).
With respect to the new reflectance photometers, the
Laboratory Standardization Panel takes the view that
they should be further tested. Particular importance
is attached to the comprehensive instructions for the
user and to the flawless completion of quality assur-
ance (3).
The objective of our examinations was to check the
precision and accuracy of the Reflotron® System for
cholesterol determination, in comparison with the Hi-
tachi 737 and SMAC automatic analysers.
Materials
— Reflotron® Cholesterol, Lot 23419631/function curve 2638
- Reflotron® No. 29952
- Precinorm® U, Lot 158096
Assigned values: Reflotron® Cholesterol 5.31 mmol/1
method of comparison 5.23 mmol/1
- Precipath®U, Lot 158019
Assigned values: Reflotron® Cholesterol 5.44 mmol/1
method of comparison 5.57 mmol/1
- Hitachi® 737 using the CHOD/PAP method, Boehringer
Mannheim (Calibrator: Beckman Level III)
- SMAC using the CHOD/PAP method, Boehringer Mann-
heim (Calibrator: Technicon Cal II)
Methods
Quality assurance
On five successive days, 10-fold determinations were carried
out using Precinorm® U, Precipath® U and two pool sera on
the three Systems, using samples with cholesterol concentrations
between 3.11 and 11.65 mmol/1. Only 10 samples had concen-
trations > 7.77 mmol/1, while the distribution below this value
was rather dense.
Method comparison
Cholesterol concentrations were determined in 85 samples from
hospitalized patients. The venous blood, treated with the anti-
coagulant lithium heparinate, was first analysed on the Reflo-
tron®. The blood was then centrifuged and the supernatant
plasma was used to determine the cholesterol value in the three
Systems.
Precinorm® U and Precipath® U were run daily for quality
control.
Statistical methods
The significance of the diflerences of values was tested by the
paired t-test. Regression analyses were performed according to
the method of Passing & Bablok (6).
Results
Quality assurance
The results for quality assurance are represented in
table l, which shows that all Systems meet the de-
mands of precision and congruence from system to
System. The CVs for the Reflotron® were between l
and 2.5%, those for the Hitachi 373 between 0.7 and
1.6% and those for the SMAC between 0.2 and 1.7%.
The values obtained on the Reflotron® with pool sera
l and 2 lay approx. 3% and 2% respectively above
those obtained with the two automated Instruments.
When the Hitachi and SMAC cholesterol values were
compared with each other, the mean deviation was
found to be only 0.026 mmol/1.
Quality assurance during the method com-
parison
Table 2 represents the day-to-day precisions obtained
with control sera in the three Systems examined. With
the Reflotron® the variance hardly increases com-
pared with the within-series precision, whereas the
day-to^day CVs of the methods of comparison are in
the same ränge äs those of the Reflotron®.
Method comparison
The mean values, Standard deviations and ranges for
the cholesterol measurements with the four methods
are given in table 3.
The regression analyses for method comparisons with
Reflotron® (cholesterol determination in plasma or
blood respectively) and comparison methods (CHOD/
PAP method on a Hitachi 737 or a SMAC Instrument
respectively) were performed according to the method
of Passing & Bablok (6).
Table 4 gives a surnmary of the six method compar-
ison studies, while figure l to figure 6 represent the
results in detail: CHOD/PAP method on a Hitachi
737 vs. Reflotron® (sample plasma) (flg. 1), CHOD/
PAP method on a SMAC vs. Reflotron® (sample:
plasma) (flg. 2), Reflotron® (sample: blood) vs. Re-
flotron® (sample: plasma) (flg. 3), CHOD/PAP
method on a Hitachi 737 vs. Reflotron® (sample:
blood) (fig. 4), CHOD/PAP method on a SMAC vs.
Reflotron® (sample: blood) (fig. 5), CHOD/PAP
method on a Hitachi 737 vs. CHOD/PAP method on
a SMAC (fig. 6).
None of the compüted slopes of the regression curves
was" significantly different from l.
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Precinorm® U 5.00 1.5
Precipath® U 4.74 2.1
Pool 1 3.73 1.1
Pool 2 8.78 2.2
Hitachi® 737
Precinorm* U 5.23 0.9
Precipath® U 5.39 0.8
Pool 1 3.57 1.0
Pool 2 8.57 1.1
SMAC®
Precinorm® U 5.26 0.6
Precipath® U 5.41 0.9
Pool 1 3.63 1.7

































































































Tab. 3. Cholesterol determination (mmol/1)
Method

















































* CHOD/PAP = Cholesterol oxidase//?-aminophenazone










Difference of means 0.091 *
(mmpl/1)
Mediän of differences 1 .9




















































* p < 0.05 ** CHOD/PAP = Cholesterol oxidase/p-aminopbenazone
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0 2 4 6 8 10 12 14
Cholesterol ICHOD-PAP, Hitachi 737; heparin plasmaHmmpl/l]
Fig. 1. Method comparison Cholesterol
x: CHOD-PAP Hitachi 737, heparin plasma;
y: Reflotron® Cholesterol, heparin plasma
N = 85











0 2 4 6 8 10 12 14
Cholesterol (Reflotron® Cholesterol;heparin bloodHmmol/1]
Fig. 3. Method comparison cholesterpl
x: Reflotron® Cholesterol, heparin blood;
y: Reflotron® Cholesterol, heparin plasma
N = 85







0 2 4 6 8 10 12 14
Cholesterol ICHOD-PAP, SMAC;heparin plasma) [mmol / l ]
Fig. 2. Method comparison cholesterol
x: CHOD-PAP SMAC, heparin plasma;
y: Reflotron® Cholesterol, heparin plasma
N = 85








0 2 4 6 8 10 12 14
Cholesterol {CHOD-PAP, Hitachi 737; heparin plasma)[mmol/l]
Fig. 4. Method comparison cholesterol
x: CHOD-P P Hitachi, heparin blood;
y: Reflotron® Cholesterol, heparin plasma
N = 85
y = -0.205 + 1.03 x
The cholesterol values obtained with Reflotron® of ± 15%. The y interceptdid not differ significantly
(sample: plasma) were slightly higher than obtained from 0.
with CHOD/PAP on a Hitachi 737 (0.091 mmol/1 or The corresponding results of the method comparison
1.9%, p < 0.05). All the results lay within the r nge with the SMAC analyser are represented in figufe 2.
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0 2 4 6 8 10 12 14
Cholesterol (CHOD-PAP,SMAC;heparin plasma) [mmol/l]
Fig. 5. Method comparison Cholesterol
x: CHOD-PAP SMAC, heparin plasma;
y: Reflotron® Cholesterol, heparin blood
N = 85









0 2 4 6 8 1 0 1 2 1 4
Cholesterol (CHOD-PAP, Hitachi 737; heparin plasma)lmmol/1]
Fig. 6. Method comparison cholesterol
x: CHOD-PAP Hitachi, heparin plasma;
y: CHOD-PAP SMAC, heparin plasma
N = 85
y == 0.129 + 1.00 x
Except for one valüe (3.276 mmol/l vs. 2.756 mmol/l),
all results also came to lie within the ränge of ± 15%.
No systematic differences between the two methods
were found. The median value of 0 was found for
both the methodical and the relative methodical dif-
ferences.
The concentration differences between blood and
plasma for the cholesterol determinations on the Re-
flotron® are represented in figure 3. Values obtained
with blood are slightly higher than those obtained
with plasma (0.104 mmol/l on average, p < 0.05). The
median value of the differences was 0.112 mmol/l or
2.2%. All the results lay within the ränge of ± 15%.
For the analysis of blood on the Reflotron® and the
analysis of plasma with the methods being compared,
pairs of test values are obtained which are symmet-
rically distributed around y = x. While the values
obtained with the Hitachi 737 did not differ signifi-
cantly from those obtained on the Reflotron®, the
SMAC results were slightly higher. The differences of
means was 0.137 mmol/l, p < 0.05. The median value
of the differences was 0.104 mmol/l or 1.8%.
In each case, one result differed by more than + or
-15% (Hitachi 737: 6.448 mmol/l, SMAC: 6.526
mmol/l, Reflotron® (sample: blood): 7.592 mmol/l
and Hitachi 737: 3.120 mmol/l, SMAC: 3.276 mmol/l,
Reflotron® (sample: blood): 2.626 mmol/l).
A comparison of cholesterol concentrations in plasma
obtained with the two automatic Instruments is shown
in figure 6. The SMAC values were systematically
higher than the Hitachi 737 values, and the difference
of means was 0.124 mmol/l, p < 0.05. The median
value of the differences was 0.137 mmol/l or 2.3%.
Discussion
Since the introduction of Reflotron® Cholesterol,
greatly differing results have been reported on its
precision and accuracy (4, 5, 7, 8). Frequently, the
authors came to the conclusion that the test results
obtained with this System were too low, thus falsely
classifying a patient requiring treatment äs healthy
(7, 8).
Our examinations revealed a close agreement between
the Reflotron® Cholesterol results and those of au-
tomatic Systems, when all Systems were working under
strictly observed conditions. Prerequisites are an ex-
perienced team in control of the analytical problems
of the cholesterol determination (pre-analytics) on the
automatic Systems, and a good instruction in the use
of the Reflotron® System, äs already shown by
M. Rohac (9).
These results confirm that the Reflotron® Cholesterol
test meets the rigid demands of the Laboratory Stand-
ardization Panel for cholesterol determination in the
clinical laboratory.
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